Our Company

1-3 of 3

The effect of a pediatric rare disease on subscriber retention rates for commercial health insurers in the United States03 October 2018 - By Edmund J. Pezalla and Samuel R. Nussbaum and Melanie K. Kuester and Elizabeth Anne Jackson and Brenda Runyan - Article

Insurers, policymakers, and government agencies in the United States may find it useful to have an accurate expectation for the length of enrollment by subscribers with a dependent who suffers from a pediatric rare disease and may be a candidate for a regenerative therapy with a potentially prolonged benefit.

Incidence rate of females with hemophilia may be underreported02 June 2017 - By Brenda Runyan and Melanie K. Kuester - Article

Hemophilia, a bleeding disorder, is traditionally known as a condition affecting males. But it’s possible for females to have hemophilia. This paper discusses some reasons why hemophilia may go undiagnosed in women.

Current perspectives of U.S. Managed Care Organizations and Pharmacy Benefit Managers on the availability of 10 mg Lipitor OTC09 December 2015 - By Brenda Runyan and Elizabeth Anne Jackson - Article

Milliman conducted market research with pharmacy and therapeutics committee members of U.S. managed care organizations and pharmacy benefit managers to gain their perspectives on the potential availability of 10 mg Lipitor over-the-counter.


  • Work at Milliman

    • “I was offered a chance to come in, shake things up, create something."
    Work at Milliman